Table 3 Performance of the BYG Carba v2.0 according to carbapenemase family.
Retrospectively (n = 511) Spec: 100% (CI95: 97.1–100) | Prospectively (n = 670) Spec: 99.7% (CI95: 97.9–100) | Total (n = 1181) Spec: 99.7% (CI95: 98.6–100) | |||
|---|---|---|---|---|---|
Sens (%) (CI95) | Sens (%) (CI95) | PPV (%) (CI95) | NPV (%) (CI95) | Sens (%) (CI95) | |
CPE | 94.8 (91.8–96.8) | 97.7 (95.4–98.9) | 99.7 (98.2–100) | 97.5 (94.9–98.8) | 96.3 (94.5–97.5) |
OXA-48-like | 96.1 (90.6–98.5) | 97.8 (94.8–99.2) | 99.6 (97.2–100) | 98.4 (96.1–99.4) | 97.2 (94.8–98.6) |
KPC | 100 (93.6–100) | 100 (89.8–100) | 97.7 (86.5–99.9) | 100 (98.5–100) | 100 (95.9–100) |
NDM | 93.3 (83.0–97.8) | 97.9 (87.3–99.9) | 97.9 (87.3–99.9) | 99.7 (97.9–100) | 95.3 (88.9–98.2) |
VIM | 98.1 (88.4–99.9) | 92.3 (73.4–98.6) | 96.0 (77.7–99.8) | 99.4 (97.4–100) | 96.1 (88.4–99.0) |
IMP | 86.7 (58.4–97.6) | 100 (19.8–100) | 66.7 (12.5–98.2) | 100 (98.5–100) | 88.2 (62.2–97.9) |
OXA-48-like + NDM | 100 (59.8–100) | 100 (51.7–100) | 85.7 (42.0–99.2) | 100 (98.5–100) | 100 (73.2–100) |